Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prenetics Global Limited - Class A Ordinary Share (NQ: PRE )

4.430 +0.070 (+1.61%)
Streaming Delayed Price Updated: 12:36 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Prenetics Global Limited - Class A Ordinary Share

< Previous 1 2 Next >
Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces Second Quarter 2024 Financial Results
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
From Prenetics Limited
Via GlobeNewswire
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
From Prenetics Global Limited
Via ACN Newswire
Prenetics Global (NASDAQ: PRE): Bending Biotech with Beckham
Via AB Newswire
Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
From Prenetics Limited
Via GlobeNewswire
Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness 
From Prenetics Limited
Via GlobeNewswire
Prenetics Global Limited (NASDAQ: PRE): Genomic Innovations Making Waves in Cancer Care
Via AB Newswire
Prenetics Announces First Quarter 2024 Financial Results
From Prenetics Limited
Via GlobeNewswire
Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
~ Emphasizes Strong Cash Position, No Debt, and A Dedicated Management Team Focused on Delivering Growth and Value to Shareholders ~ 
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces Third Quarter 2023 Financial Results
From Prenetics Limited
Via GlobeNewswire
Prenetics Global Limited Announces Reverse Stock Split
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces Second Quarter 2023 Financial Results
From Prenetics Limited
Via GlobeNewswire
Prenetics Global signs "transformational" $200mln deal to create cancer screening JV
Prenetics Global Ltd (NASDAQ:PRE) CEO Danny Yeung speaks to Thomas Warner from Proactive after announcing a $200mln deal to create a multi-cancer early detection screening joint venture with Professor... 
Via TheNewswire.com
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening
Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT 
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces First Quarter 2023 Financial Results
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
New Business Strategy Focused on Precision Oncology 
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
From Prenetics Limited
Via GlobeNewswire
Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA
From Prenetics Limited
Via GlobeNewswire
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
From Prenetics Limited
Via GlobeNewswire
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
From Prenetics Limited
Via GlobeNewswire
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics
From Prenetics Global Limited
Via ACN Newswire
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
From Prenetics Limited
Via GlobeNewswire
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
From Prenetics Global Limited
Via ACN Newswire
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
Via ACN Newswire
Exposures COVID-19
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
From Prenetics Limited
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.